大麻产品上的健康警告标签. 什么是最好的设计?
Carlos Gantiva1, Joseph Illidge-Cortes1, Danna González-Millares1
1Universidad de los Andes, Bogotá Colombia.
The International journal on drug policy
|February 21, 2024
概括
大麻产品上的图形健康警告,特别是带有黄色背景的,是最有效的. 这些警告降低了产品的吸引力和兴趣,同时增加了对更好的风险沟通的危害感知.
科学领域:
- 公共卫生 公共卫生
- 大麻法规大麻法规大麻法规
- 卫生沟通健康沟通
背景情况:
- 随着全球法规的不断变化,大麻产品上需要有效的健康警告标签.
- 需要进行研究来确定大麻健康警告的最佳策略.
研究的目的:
- 评估不同健康警告标签设计对大麻产品的影响.
- 为了比较图像和纯文本标签,背景颜色和警告主题.
主要方法:
- 在哥伦比亚进行了一项在线实验,其中533名参与者使用了跨主体设计.
- 参与者接受了五种条件:没有警告,只有文字 (白色/黄色) 和图像 (白色/黄色) 的警告.
- 收集的数据包括注意力,产品吸引力,感知成性,伤害感知和尝试大麻的兴趣.
主要成果:
- 图像健康警告显著超过了纯文本警告.
- 黄色背景图像警告是最有效的,减少了吸引力和兴趣,增加了伤害感知.
- 有效的警告主题包括心理健康,烟雾毒性,美学影响和交通事故.
结论:
- 该研究提供了经验证据,支持特定大麻健康警告标签设计的有效性.
- 建议使用图形黄色背景警告来有效传达大麻风险.
相关概念视频
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Pharmacovigilance
833
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
833
Labeling DNA Probes
8.2K
DNA probes are fragments of DNA labeled with a reporter tag to enable their detection or purification. The resulting labeled DNA probes can then hybridize to target nucleic acid sequences through complementary base-pairing, and may be used to recover or identify these regions.
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
8.2K
Drug Control Governance: Regulatory Bodies and Their Impact
158
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
158
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
278
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
278
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K


